Emerging Trends in Industry

With reductions in public funding and amid enhanced attrition, costs and competition in drug development, the benefits to academic researchers, research institutions and industry for open collaborative partnerships is greater than ever before. While basic science breakthroughs continue to be crucial, more immediate and predicted practical impact have become increasingly essential to all parties. Consequently, more collaborative, shared-risk/reward, smaller ´pilot’ partnerships are becoming the more typical relationship between industry and research institutions. Those limiting their institutions to the large, open-ended and fee-for-service contracts are likely to find increasing frustration as this decade progresses. Understanding this emerging vision for mutually productive collaborations will allow your research institute to compete effectively for the increasingly more competitive funding, notoriety and, yes, royalties, now and in the foreseeable future.